Jaguar Health (NASDAQ: JAGX) stock plunged 35% in intraday trading Monday as the company prepares to implement a reverse stock […]
Jaguar Health (NASDAQ: JAGX) Stock Plummets Ahead of Reverse Stock Split Read More »
Jaguar Health (NASDAQ: JAGX) stock jumped about 16% in intraday trading after the company submitted clinical trial applications for Crofelemer
Jaguar Health (NASDAQ: JAGX) Stock Rallies on European Clinical Trial Milestone Read More »
Jaguar Health (NASDAQ: JAGX) stock is garnering attention following the appointment of a new Senior Vice President (SVP) of Growth
Jaguar Health (NASDAQ: JAGX) Names New Senior VP to Drive Growth Strategy, Stock Jumps Read More »
Jaguar Health (NASDAQ: JAGX) stock soared over 50% in intraday trading after the company inked an exclusive 5-year in-license agreement
Jaguar Health (NASDAQ: JAGX) Stock Skyrockets on Key Licensing Agreement Read More »
Jaguar Health (NASDAQ: JAGX) stock plunged over 5% in the pre-market trading Tuesday after the company reported a year-over-year decline
Jaguar Health (NASDAQ: JAGX) Stock Tumbles Amid Disappointing Q4 Results Read More »
Jaguar Health (NASDAQ: JAGX) stock soared following the announcement that GEN will commercialize Jaguar’s crofelemer in Turkey and eight neighboring
Jaguar Health (NASDAQ: JAGX) Partners with GEN, Stock Gains Momentum Read More »
Jaguar Health (NASDAQ: JAGX) stock soared 50% on Friday without any company-specific news for the session. Jaguar Health (JAGX) disclosed
Jaguar Health (NASDAQ: JAGX) Stock Skyrockets 50%: What’s Going On? Read More »
